Dr. Charles E. Egwuagu is an immunologist, infectious disease epidemiologist, and Chief of the molecular immunology section of the National Eye Institute (NEI) and National Institutes of Health (NIH) in Bethesda, Maryland. Dr. Egwuagu received his PhD in epidemiology and microbiology and his M.Phil. in immunology and parasitology from Yale University Graduate School.  He also obtained his Master of Public Health (M.P.H) degree in infectious disease epidemiology from the Yale School of Medicine in New Haven, Connecticut. Dr. Egwuagu did a 2-year post-doctoral fellowship in molecular immunology at NIH and then served as a Commissioned Officer of the United States Public Health Service (PHS) for 10 years, attaining the rank of Captain (06). Research in the Egwuagu laboratory is on mechanisms that mediate Central Nervous System (CNS) autoimmune diseases, including Uveitis and Multiple Sclerosis. His particular interest is on cytokine signaling and epigenetic mechanisms that regulate lymphocyte development and cell-fate decisions. Dr. Egwuagu’s ultimate goal is to develop biologics and regulatory B cell (Breg) immunotherapy for autoimmune and neurodegenerative diseases.